Incyte Corporation and MacroGenics, Inc. Company Profile

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical
company focused on the discovery, development and commercialization of
proprietary therapeutics. For additional information on Incyte, please
visit the Companyâs website at www.incyte.com.

MacroGenics and Cardinal Health are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendatio...

MacroGenics Inc. (therapeutic antibodies for cancer, autoimmune disorders, and infectious diseases) netted $90mm through a public offering of 4.5mm common shares at $21.25. Proceeds will support worki...

MacroGenics Inc. (therapeutic antibodies for cancer, autoimmune disorders, and infectious diseases) netted $103.4mm through a public offering of 5.2mm common shares (including the overallotment) at $2...

MacroGenics is a private, venture-backed biotechnology company that focuses on the discovery, development and delivery to patients of novel biologics for autoimmune disorders, cancer and infectious di...

Relevant Topic

BiopharmaceuticalsBiopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...